期刊文献+

胰腺癌中CIP2A与p-Akt、N-cadherin、MMP-9的表达及其临床意义 被引量:5

Expression and signifance of CIP2A, p-Akt, N-cadherin and MMP-9 in pancreatic carcinoma
在线阅读 下载PDF
导出
摘要 目的:探讨胰腺癌组织中蛋白磷酸酶2A癌性抑制因子(CIP2A)、p-Akt、N-cadherin及MMP-9蛋白的表达及其临床意义。方法:采用免疫组织化学法检测42例胰腺癌及癌旁组织中CIP2A、p-Akt、N-cadherin和MMP-9的表达情况,分析其与临床病理因素的关系。结果:CIP2A在胰腺癌及癌旁组织中的表达率分别为71.4%、7.7%,差异有统计学意义(P<0.05);p-Akt在胰腺癌及癌旁组织中的表达率分别为66.7%、11.5%,差异有统计学意义(P<0.05)。N-cadherin在胰腺癌及癌旁组织中的表达率分别为59.5%、7.7%,差异有统计学意义(P<0.05)。MMP-9在胰腺癌组织及癌旁组织中的表达率分别为61.9%、15.4%,差异有统计学意义(P<0.05)。CIP2A、p-Akt在胰腺癌组织中的表达与分化程度、TNM分期、淋巴结转移明显相关(均P<0.05),N-cadherin、MMP-9在胰腺癌组织中的表达与分化程度、TNM分期、神经浸润、淋巴结转移明显相关(P<0.05)。胰腺癌组织中,CIP2A和p-Akt、N-cadherin和MMP-9的表达均呈正相关(均P<0.05);p-Akt与N-cadherin及MMP-9的表达均呈正相关(P<0.05);N-cadherin与MMP-9的表达呈正相关(P<0.05)。结论:CIP2A参与了胰腺癌恶性进展,可能通过PI3K/Akt信号通路诱导上皮间质转化,促进胰腺癌增殖、侵袭和转移。CIP2A有望成为治疗胰腺癌的一个靶向治疗基因。 Objective:To study the expressions of ClP2A,p-Akt,N-cadherin and MMP-9 in pancreatic carcinoma and their clinical significance.Methods:The expressions of CIP2A,p-Akt,N-cadherin and MMP-9 proteins were tested by immunohistochemistry in 42 cases of pancreatic carcinomas and adjacent paracancerous tissues.Results:The positive rate of CIP2A in pancreatic carcinomas was significantly higher than adjacent paracancerous tissues (71.4% vs 7.7%,P<0.05).Significant differences were also observed in the expression rate of p-Akt between the patients with pancreatic carcinomas and paracancerous tissues (66.7% vs 11.5%,P<0.05).The positive rate of N-cadherin in pancreatic carcinomas and paracancerous tissues (59.5% vs 7.7%,P<0.05).Significant differences were also observed in the expression rate of MMP-9 between pancreatic carcinomas and paracancerous tissues (61.9% vs 15.4%,P<0.05).The differences of the expression of CIP2A and p-Akt in pancreatic carcinoma of tumor differentiation,TNM stage and lymph node metastasis were significant (all P<0.05).The differences of the expression of N-cadherin and MMP-9 in pancreatic carcinoma of tumor differentiation,TNM stage,neural invasion and lymph node metastasis were also significant (all P<0.05).Significantly positive correlation was found between the expression of ClP2A and the others (p-Akt,N-cadherin and MMP-9) by using spearman correlation analysis (all P<0.05).Significantly positive correlation was found between the expression of p-Akt and the others (N-cadherin and MMP-9) by using spearman correlation analysis(all P<0.05).Significantly positive correlation was found between the expression of N-cadherin and MMP-9 by using spearman correlation analysis (P<0.05).Conclusion:CIP2A was involved in the development of pancreatic carcinoma and may promote EMT through the PI3K/Akt pathway.The data identified CIP2A as a critical oncoprotein involved in cell proliferation,invasion and metastasis,which could serve as a therapeutic target in pancreatic carcinoma.
出处 《中国现代普通外科进展》 CAS 2014年第10期779-783,共5页 Chinese Journal of Current Advances in General Surgery
关键词 胰腺肿瘤 蛋白磷酸酶2A癌性抑制因子 p-蛋白激酶B N-钙黏素 基质金属蛋白酶-9 上皮间质转化 Pancreatic carcinoma Cancerous inhibitor of protein phosphatase2A p-Akt N-cadherin MMP-9 Epithelial-mesenchymal Transition
  • 相关文献

参考文献20

  • 1Fry LC,Monkemüller K,Malfertheiner P.Molecular markers of pancreatic cancer:development and clinical relevance[J].Langenbecks Arch Surg,2008,393(6):883-890.
  • 2Junttila MR,Puustinen P,Niemela M,et al.CIP2A inhibits PP2A in human malignancies[J].Cell,2007,130(1):51-62.
  • 3Fruman DA,Rommel C.PI3K and cancer:lessons,challenges and opportunities[J].Nat Rev Drug Discov,2014,13(2):140-156.
  • 4Guarino M,Rubino B,Ballabio G.The role of epithelial-mesenchymal transition in cancer pathology[J].Pathology,2007,39(3):305-318.
  • 5Mialhe A,Levacher G,Champelovier P,et al.Expression of E-,P-,n-cadherins and catenins in human bladder carcinoma cell lines[J].J Urol,2000,164(3 Pt 1):826-835.
  • 6Franco-Chuaire ML,Magda Carolina SC,Chuaire-Noack L.Epithelial-mesenchymal transition(EMT):principles and clinical impact in cancer therapy[J].Invest Clin,2013,54(2):186-205.
  • 7Zeisberg M,Neilson EG.Biomarkets for epithelial-mesenehymal transitions[J].J Clin Invest,2009,119(6):1429-1437.
  • 8Dong QZ,Wang Y,Dong XJ,et al.CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis[J].Ann Surg Oncol,2011,18(3):857-865.
  • 9Soo Hoo L,Zhang JY,Chan EK.Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer[J].Oncogene,2002,21(32):5006-5015.
  • 10Junttila MR,Westermarck J.Mechamsms of MYC stabilization in human malignancies[J].Cell Cycle,2008,7(5):592-596.

二级参考文献3

共引文献1

同被引文献31

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部